English  |  正體中文  |  简体中文  |  2830311  
???header.visitor??? :  32528689    ???header.onlineuser??? :  889
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"azuma m"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-12 of 12  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-11-18T04:58:07Z Increased prevalence of interleukin-17-producing CD4 + tumor infiltrating lymphocytes in human oral squamous cell carcinoma Lee J.-J; Chang Y.-L; Lai W.-L; JENG-YUH KO; Kuo M.Y.-P; Chiang C.-P; Azuma M; Chen C.-W; Chia J.-S.
臺大學術典藏 2021-11-15T07:48:30Z Increased prevalence of interleukin-17-producing CD4 + tumor infiltrating lymphocytes in human oral squamous cell carcinoma Lee J.-J; Chang Y.-L; Lai W.-L; JENG-YUH KO; Kuo M.Y.-P; Chiang C.-P; Azuma M; Chen C.-W; Chia J.-S.
臺大學術典藏 2021-07-07T01:46:55Z Increased prevalence of interleukin-17-producing CD4 + tumor infiltrating lymphocytes in human oral squamous cell carcinoma JANG-JAER LEE; Chang Y.-L.; Lai W.-L.; Ko J.-Y.; Kuo M.Y.-P.; Chiang C.-P.; Azuma M.; Chen C.-W.; Chia J.-S.
臺大學術典藏 2021-07-05T05:42:08Z Increased prevalence of interleukin-17-producing CD4 + tumor infiltrating lymphocytes in human oral squamous cell carcinoma Lee J.-J.; Chang Y.-L.; Lai W.-L.; Ko J.-Y.; YEN-PING KUO; Chiang C.-P.; Azuma M.; Chen C.-W.; Chia J.-S.
臺大學術典藏 2020-04-21T03:51:57Z 63Cu NQR evidence of dimensional crossover to anisotropic 2d regime in S = 1/2Three-Leg Ladder Sr2Cu3O5 Thurber, K. R.; Imai, T.; Saitoh, T.; Azuma, M.; Takano, M.; Chou, F. C.
國立成功大學 2019 Safety and efficacy of nivolumab in combination with s-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (a Boku, N.;Ryu, M.-H.;Kato, Kato K.;Chung, H.C.;Minashi, K.;Lee, K.-W.;Cho, H.;Kang, W.K.;Komatsu, Y.;Tsuda, M.;Yamaguchi, K.;Hara, Hara H.;Fumita, S.;Azuma, M.;Chen, L.-T.;Kang, Y.-K.
國立成功大學 2019 A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy re Kato, Kato K.;Satoh, T.;Muro, K.;Yoshikawa, T.;Tamura, Tamura T.;Hamamoto, Y.;Chin, K.;Minashi, K.;Tsuda, M.;Yamaguchi, K.;Machida, N.;Esaki, T.;Goto, M.;Komatsu, Y.;Nakajima, T.E.;Sugimoto, N.;Yoshida, K.;Oki, E.;Nishina, T.;Tsuji, A.;Fujii, H.;Kunieda, Kunieda K.;Saitoh, Saitoh S.;Omuro, Y.;Azuma, M.;Iwamoto, Y.;Taku, K.;Fushida, S.;Chen, L.-T.;Kang, Y.-K.;Boku, N.
國家衛生研究院 2018-12-19 Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase 2 trial (AT Boku, N;Ryu, MH;Kato, K;Chung, HC;Minashi, K;Lee, KW;Cho, H;Kang, WK;Komatsu, Y;Tsuda, M;Yamaguchi, K;Hara, H;Fumita, S;Azuma, M;Chen, LT;Kang, YK
國家衛生研究院 2018-12-01 A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens Kato, K;Satoh, T;Muro, K;Yoshikawa, T;Tamura, T;Hamamoto, Y;Chin, K;Minashi, K;Tsuda, M;Yamaguchi, K;Machida, N;Esaki, T;Goto, M;Komatsu, Y;Nakajima, TE;Sugimoto, N;Yoshida, K;Oki, E;Nishina, T;Tsuji, A;Fujii, H;Kunieda, K;Saitoh, S;Omuro, Y;Azuma, M;Iwamoto, Y;Taku, K;Fushida, S;Chen, LT;Kang, YK;Boku, N
國家衛生研究院 2017-09 Interim safety and clinical activity of nivolumab (Nivo) in combination with S-1/capecitabine plus oxaliplatin in patients (pts) with previously untreated unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: part 1 study of ATTRACTION-04 (ONO-4538-37) Kang, YK;Kato, K;Chung, HC;Minashi, K;Lee, KW;Cho, H;Kang, WK;Komatsu, Y;Tsuda, M;Yamaguchi, K;Hara, H;Fumita, S;Azuma, M;Boku, N;Chen, LT
國立臺灣大學 2006-01 TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Sabaawy, HE; Azuma, M; Embree, LJ; Tsai, HJ; Starost, MF; Hickstein, DD
國立臺灣大學 2000-01 63Cu NQR Evidence of Dimensional Crossover to Anisotropic 2D Regime in S = 1/2 Three-Leg Ladder Sr2Cu3O5 Thurber, K. R.; Imai, T.; Saitoh, T.; Azuma, M.; Takano, M.; Chou, F. C.

Showing items 1-12 of 12  (1 Page(s) Totally)
1 
View [10|25|50] records per page